Jilkina Olga, Kuzio Bozena, Kupriyanov Valery V
Institute for Biodiagnostics, National Research Council of Canada, 435 Ellice Avenue, Winnipeg, MB R3B1Y6, Canada.
Can J Physiol Pharmacol. 2008 Oct;86(10):710-25. doi: 10.1139/y08-076.
We evaluated the function of Na(+)/K(+) ATPase and sarcolemmal K(ATP) channels in diabetic rat hearts. Six weeks after streptozotocin (STZ) injection, unidirectional K(+) fluxes were assayed by using (87)rubidium ((87)Rb(+)) MRS. The hearts were loaded with Rb(+) by perfusion with Krebs-Henseleit buffer, in which 50% of K(+) was substituted with Rb(+). The rate constant of Rb(+) uptake via Na(+)/K(+) ATPase was reduced. K(ATP)-mediated Rb(+) efflux was activated metabolically with 2,4-dinitrophenol (DNP, 50 micromol.L(-1)) or pharmacologically with a K(ATP) channel opener, P-1075 (5 micromol.L(-1)). Cardiac energetics were monitored by using (31)P MRS and optical spectroscopy. DNP produced a smaller ATP decrease, yet similar Rb(+) efflux activation in STZ hearts. In K(+)-arrested hearts, P-1075 had no effect on high-energy phosphates and stimulated Rb(+) efflux by interaction with SUR2A subunit of K(ATP) channel; this stimulation was greater in STZ hearts. In normokalemic hearts, P-1075 caused cardiac arrest and ATP decline, and the stimulation of Rb(+) efflux was lower in normokalemic STZ hearts arrested by P-1075. Thus, the Rb(+)efflux stimulation in STZ hearts was altered depending on the mode of K(ATP) channel activation: pharmacologic stimulation (P-1075) was enhanced, whereas metabolic stimulation (DNP) was reduced. Both the basal concentration of phosphocreatine ([PCr]) and [PCr]/[ATP] were reduced; nevertheless, the STZ hearts were more or equally resistant to metabolic stress.
我们评估了糖尿病大鼠心脏中Na(+)/K(+)ATP酶和肌膜K(ATP)通道的功能。注射链脲佐菌素(STZ)六周后,使用(87)铷((87)Rb(+))磁共振波谱法测定单向K(+)通量。通过用Krebs-Henseleit缓冲液灌注使心脏加载Rb(+),其中50%的K(+)被Rb(+)替代。通过Na(+)/K(+)ATP酶摄取Rb(+)的速率常数降低。K(ATP)介导的Rb(+)外流通过2,4-二硝基苯酚(DNP,50μmol·L(-1))进行代谢激活,或通过K(ATP)通道开放剂P-1075(5μmol·L(-1))进行药理学激活。使用(31)P磁共振波谱法和光学光谱法监测心脏能量代谢。DNP使STZ心脏中的ATP减少幅度较小,但Rb(+)外流激活程度相似。在K(+)停搏的心脏中,P-1075对高能磷酸盐无影响,并通过与K(ATP)通道的SUR2A亚基相互作用刺激Rb(+)外流;这种刺激在STZ心脏中更大。在正常血钾的心脏中,P-1075导致心脏停搏和ATP下降,并且在被P-1075停搏的正常血钾STZ心脏中,Rb(+)外流的刺激较低。因此,STZ心脏中Rb(+)外流刺激根据K(ATP)通道激活模式而改变:药理学刺激(P-1075)增强,而代谢刺激(DNP)减弱。磷酸肌酸([PCr])的基础浓度和[PCr]/[ATP]均降低;然而,STZ心脏对代谢应激更具抵抗力或同样具有抵抗力。